Literature DB >> 8384692

Effect of CPT on the calf thymus Topoisomerase I-mediated DNA breakage-reunion reaction: optimal conditions for the formation and reversal of the CPT trapped Topoisomerase I cleavable complex.

S Coderoni1, M Paparelli, G L Gianfranceschi.   

Abstract

The effects of CPT on the calf thymus Topoisomerase I-mediated DNA breakage-reunion reaction were studied at an enzyme concentration range proper for evidencing, at the same time, both DNA relaxation and DNA cleavage/religation. Some of the requirements and the optimal conditions for the formation and reversal of the CPT-trapped Topoisomerase I-DNA cleavable complex are also characterized. We conclude that: 1. Calf thymus (100 kDa) Topoisomerase I requires, for maximal DNA cleavage activity, specific and characteristic reaction conditions. 2. CPT does not affect these optimal conditions, but only stabilizes the normal enzyme-DNA intermediate. In this way, the drug lowers the religation process, becoming responsible for the relaxation inhibition. 3. The optimum of monovalent salt concentration for cleavable complex formation is found between 30 and 70 mM. These values are lower than those required for the relaxation activity optimum (75-125 mM NaCl). 4. The addition of 0.5 M monovalent salt causes reversal of the reaction, and shifts the equilibrium distribution between cleavable intermediate and closed relaxed DNA in the direction of DNA resealing. Therefore, it is suggested that salt affects the cleavage but not the religation reaction.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8384692     DOI: 10.1007/bf00996220

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  20 in total

Review 1.  DNA topoisomerase poisons as antitumor drugs.

Authors:  L F Liu
Journal:  Annu Rev Biochem       Date:  1989       Impact factor: 23.643

Review 2.  Topoisomerase-targeting antitumor drugs.

Authors:  P D'Arpa; L F Liu
Journal:  Biochim Biophys Acta       Date:  1989-12-17

3.  Involvement of DNA topoisomerase I in transcription of human ribosomal RNA genes.

Authors:  H Zhang; J C Wang; L F Liu
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

4.  Roles of DNA topoisomerases in simian virus 40 DNA replication in vitro.

Authors:  L Yang; M S Wold; J J Li; T J Kelly; L F Liu
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

5.  Irreversible trapping of the DNA-topoisomerase I covalent complex. Affinity labeling of the camptothecin binding site.

Authors:  R P Hertzberg; R W Busby; M J Caranfa; K G Holden; R K Johnson; S M Hecht; W D Kingsbury
Journal:  J Biol Chem       Date:  1990-11-05       Impact factor: 5.157

6.  Sequence-dependent effect of camptothecin on human topoisomerase I DNA cleavage.

Authors:  E Kjeldsen; S Mollerup; B Thomsen; B J Bonven; L Bolund; O Westergaard
Journal:  J Mol Biol       Date:  1988-07-20       Impact factor: 5.469

7.  Phosphorylation sites for type N II protein kinase in DNA-topoisomerase I from calf thymus.

Authors:  S Coderoni; M Paparelli; G L Gianfranceschi
Journal:  Int J Biochem       Date:  1990

8.  On the mechanism of topoisomerase I inhibition by camptothecin: evidence for binding to an enzyme-DNA complex.

Authors:  R P Hertzberg; M J Caranfa; S M Hecht
Journal:  Biochemistry       Date:  1989-05-30       Impact factor: 3.162

9.  Protein-linked DNA strand breaks induced in mammalian cells by camptothecin, an inhibitor of topoisomerase I.

Authors:  J M Covey; C Jaxel; K W Kohn; Y Pommier
Journal:  Cancer Res       Date:  1989-09-15       Impact factor: 12.701

10.  Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I.

Authors:  Y H Hsiang; R Hertzberg; S Hecht; L F Liu
Journal:  J Biol Chem       Date:  1985-11-25       Impact factor: 5.157

View more
  1 in total

1.  DNA-Binding and Topoisomerase-I-Suppressing Activities of Novel Vanadium Compound Van-7.

Authors:  Xiao-Mei Mo; Zhan-Fang Chen; Xin Qi; Yan-Tuan Li; Jing Li
Journal:  Bioinorg Chem Appl       Date:  2012-09-30       Impact factor: 7.778

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.